Roussel-Uclaf to transfer RU 486 rights.
D000019:Abortifacient Agents; D000028:Abortion, Induced; D000569:Americas; D001695:Biology; D003132:Commerce; D019049:Developed Countries; D004467:Economics; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D005602:France; D005858:Germany; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone; D009656:North America; D009938:Organizations; D010827:Physiology; D011057:Politics; D011639:Public Opinion; D012537:Scandinavian and Nordic Countries; D013548:Sweden; D006113:United Kingdom; D014481:United States
D000019:Abortifacient Agents; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Americas; Anti-abortion Groups; Biology; Commerce; Developed Countries; Economic Factors; Endocrine System; Europe; Family Planning; Fertility Control, Postconception; France; Germany; Hormone Antagonists; Hormones; Interest Groups; Macroeconomic Factors; Mediterranean Countries; Nongovernmental Organizations; North America; Northern America; Northern Europe; Organizations; Physiology; Political Factors; Ru-486; Scandinavia; Sweden; United Kingdom; United States; Western Europe